Skip to main content

Advertisement

Log in

Medication-overuse headache in patients with cluster headache

  • Published:
Current Pain and Headache Reports Aims and scope Submit manuscript

Abstract

Cluster headache (CH) is associated with the most severe pain of the primary headache disorders. Barriers to optimal care include misdiagnosis, diagnostic delay, undertreatment, and mismanagement. Medication-over-use headache (MOH) may further complicate CH and may present as increased CH frequency or development of a background headache, which may be featureless or have some migrainous quality. A personal or familial history of migraine appears to be strongly associated with the development of MOH in CH, at least with the phenotype of background headache. Patients with CH, especially those with a personal and/or family history of migraine, must be carefully monitored for MOH, and medication withdrawal should be considered if a CH patient presents with features of MOH.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Subscribe and save

Springer+ Basic
EUR 32.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or Ebook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Capobianco DJ, Swanson JW, Dodick DW: Medication-induced (analgesic rebound) headache: historical aspects and initial descriptions of the North American experience. Headache 2001, 41:500–502.

    Article  CAS  PubMed  Google Scholar 

  2. Diener HC, Limmroth V: Medication-overuse headache: a worldwide problem. Lancet Neurol 2004, 3:475–483.

    Article  PubMed  Google Scholar 

  3. Headache Classification Committee of the International Headache Society: Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988, 8(Suppl 7):1–96.

    Google Scholar 

  4. Headache Classification Subcommittee of the International Headache Society: The International Classification of Headache Disorders: 2nd edition. Cephalalgia 2004, 24(Suppl 1):9–160.

    Google Scholar 

  5. Headache Classification Committee, Olesen J, Bousser MG, et al.: New appendix criteria open for a broader concept of chronic migraine. Cephalalgia 2006, 26:742–746.

    Article  CAS  PubMed  Google Scholar 

  6. Limmroth V, Katsarava Z, Fritsche G, et al.: Features of medication overuse headache following overuse of different acute headache drugs. Neurology 2002, 59:1011–1014.

    CAS  PubMed  Google Scholar 

  7. Young WB, Silberstein S: Hemicrania continua and symptomatic medication overuse. Headache 1993, 33:485–487.

    Article  CAS  PubMed  Google Scholar 

  8. Evans RW: New daily persistent headache. Curr Pain Headache Rep 2003, 7:303–307.

    Article  PubMed  Google Scholar 

  9. Zeeberg P, Olesen J, Jensen R: Probable medication-overuse headache: the effect of a 2-month drug-free period. Neurology 2006, 66:1894–1898.

    Article  PubMed  Google Scholar 

  10. Paemeleire K, Crevits L, Goadsby PJ, Kaube H: Practical management of medication-overuse headache. Acta Neurol Belg 2006, 106:43–51.

    PubMed  Google Scholar 

  11. Torelli P, Manzoni GC: Pain and behaviour in cluster headache. A prospective study and review of the literature. Funct Neurol 2003, 18:205–210.

    PubMed  Google Scholar 

  12. Russell MB: Epidemiology and genetics of cluster headache. Lancet Neurol 2004, 3:279–283.

    Article  PubMed  Google Scholar 

  13. May A, Bahra A, Büchel C, et al.: Hypothalamic activation in cluster headache attacks. Lancet 1998, 352:275–278.

    Article  CAS  PubMed  Google Scholar 

  14. Katsarava Z, Obermann M, Yoon MS, et al.: Prevalence of cluster headache in a population-based sample in Germany. Cephalalgia 2007, 27:1014–1019.

    Article  CAS  PubMed  Google Scholar 

  15. van Vliet JA, Eekers PJ, Haan J, Ferrari MD; Dutch RUSSH Study Group: Features involved in the diagnostic delay of cluster headache. J Neurol Neurosurg Psychiatry 2003, 74:1123–1125.

    Article  PubMed  Google Scholar 

  16. Bahra A, Goadsby PJ: Diagnostic delays and mismanagement in cluster headache. Acta Neurol Scand 2004, 109:175–179.

    Article  CAS  PubMed  Google Scholar 

  17. Klapper JA, Klapper A, Voss T: The misdiagnosis of cluster headache: a nonclinic, population-based, Internet survey. Headache 2000, 40:730–735.

    Article  CAS  PubMed  Google Scholar 

  18. Kernick D, Matharu MS, Goadsby PJ: Cluster headache in primary care: unmissable, underdiagnosed and undertreated. Br J Gen Pract 2006, 56:486–487.

    PubMed  Google Scholar 

  19. Jensen RM, Lyngberg A, Jensen RH: Burden of cluster headache. Cephalalgia 2007, 27:535–541.

    Article  CAS  PubMed  Google Scholar 

  20. Ekbom K, Waldenlind E, Cole J, et al.: Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 1992, 12:254–256.

    Article  CAS  PubMed  Google Scholar 

  21. Centonze V, Bassi A, Causarano V, et al.: Sumatriptan overuse in episodic cluster headache: lack of adverse events, rebound syndromes, drug dependence and tachyphylaxis. Funct Neurol 2000, 15:167–170.

    CAS  PubMed  Google Scholar 

  22. Ekbom K, Waldenlind E, Cole J, et al.: Sumatriptan in chronic cluster headache: results of continuous treatment for eleven months. Cephalalgia 1992, 12:254–256.

    Article  CAS  PubMed  Google Scholar 

  23. Ekbom K, Krabbe A, Micieli G, et al.: Cluster headache attacks treated for up to three months with subcutaneous sumatriptan (6 mg). Sumatriptan Cluster Headache Long-term Study Group. Cephalalgia 1995, 15:230–236.

    Article  CAS  PubMed  Google Scholar 

  24. Monstad I, Krabbe A, Micieli G, et al.: Preemptive oral treatment with sumatriptan during a cluster period. Headache 1995, 35:607–613.

    Article  CAS  PubMed  Google Scholar 

  25. Hering-Hanit R: Alteration in nature of cluster headache during subcutaneous administration of sumatriptan. Headache 2000, 40:41–44.

    Article  CAS  PubMed  Google Scholar 

  26. Göbel H, Lindner V, Heinze A, et al.: Acute therapy for cluster headache with sumatriptan: findings of a one-year long-term study. Neurology 1998, 51:908–911.

    PubMed  Google Scholar 

  27. Dousset V, Chrysostome V, Ruiz B, et al.: Does repeated subcutaneous administration of sumatriptan produce an unfavorable evolution in cluster headache? J Headache Pain 2004, 5:110–114.

    Article  CAS  Google Scholar 

  28. Rossi P, Lorenzo GD, Formisano R, Buzzi MG: Subcutaneous sumatriptan induces changes in frequency pattern in cluster headache patients. Headache 2004, 44:713–718.

    Article  PubMed  Google Scholar 

  29. Hardebo JE: Subcutaneous sumatriptan in cluster headache: a time study of the effect on pain and autonomic symptoms. Headache 1993, 33:18–21.

    Article  CAS  PubMed  Google Scholar 

  30. Evers S, Bauer B, Suhr B: Ergotamine-induced headache associated with cluster headache. Neurology 1996, 46:291.

    CAS  PubMed  Google Scholar 

  31. Paemeleire K, Bahra A, Evers S, et al.: Medication-overuse headache in patients with cluster headache. Neurology 2006, 67:109–113.

    Article  CAS  PubMed  Google Scholar 

  32. Goadsby PJ: Is medication-overuse headache a distinct biological entity? Nat Clin Pract Neurol 2006, 2:401.

    Article  PubMed  Google Scholar 

  33. Bahra A, Walsh M, Menon S, Goadsby PJ: Does chronic daily headache arise de novo in association with regular use of analgesics? Headache 2003, 43:179–190.

    Article  PubMed  Google Scholar 

  34. Wilkinson SM, Becker WJ, Heine JA: Opiate use to control bowel motility may induce chronic daily headache in patients with migraine. Headache 2001, 41:303–309.

    Article  CAS  PubMed  Google Scholar 

  35. Evans RW, Bahra A: Migraine and cluster headache: coexistence, laterality, and gender. Headache 2004, 44:186–188.

    Article  PubMed  Google Scholar 

  36. Bahra A, May A, Goadsby PJ: Cluster headache: a prospective clinical study with diagnostic implications. Neurology 2002, 58:354–361.

    PubMed  Google Scholar 

  37. Zwart JA, Dyb G, Hagen K, et al.: Analgesic use: a predictor of chronic pain and medication overuse headache: the Head-HUNT Study. Neurology 2003, 61:160–164.

    PubMed  Google Scholar 

  38. Srikiatkhachorn A, Tarasub N, Govitrapong P: Effect of chronic analgesic exposure on the central serotonin system: a possible mechanism of analgesic abuse headache. Headache 2000, 40:343–350.

    Article  CAS  PubMed  Google Scholar 

  39. Ayzenberg I, Obermann M, Nyhuis P, et al.: Central sensitization of the trigeminal and somatic nociceptive systems in medication overuse headache mainly involves cerebral supraspinal structures. Cephalalgia 2006, 26:1106–1114.

    Article  CAS  PubMed  Google Scholar 

  40. Fumal A, Laureys S, Di Clemente L, et al.: Orbitofrontal cortex involvement in chronic analgesic-overuse headache evolving from episodic migraine. Brain 2006, 129:543–550.

    Article  PubMed  Google Scholar 

  41. Cohen AS, Matharu MS, Burns B, Goadsby PJ: Randomized double-blind, placebo-controlled trial of high-flow inhaled oxygen in acute cluster headache. Cephalalgia 2008, In press.

  42. Fogan L: Treatment of cluster headache. A double-blind comparison of oxygen v air inhalation. Arch Neurol 1985, 42:362–363.

    CAS  PubMed  Google Scholar 

  43. May A: Cluster headache: pathogenesis, diagnosis, and management. Lancet 2005, 366:843–855.

    Article  PubMed  Google Scholar 

  44. van Vliet JA, Bahra A, Martin V, et al.: Intranasal sumatriptan in cluster headache: randomized placebo-controlled double-blind study. Neurology 2003, 60:630–633.

    Article  PubMed  Google Scholar 

  45. Cittadini E, May A, Straube A, et al.: Effectiveness of intranasal zolmitriptan in acute cluster headache: a randomized, placebo-controlled, double-blind crossover study. Arch Neurol 2006, 63:1537–1542.

    Article  PubMed  Google Scholar 

  46. Rapoport AM, Mathew NT, Silberstein SD, et al.: Zolmitriptan nasal spray in the acute treatment of cluster headache: a double-blind study. Neurology 2007, 69:821–826.

    Article  CAS  PubMed  Google Scholar 

  47. May A, Leone M, Afra J, et al.: EFNS Task Force: EFNS guidelines on the treatment of cluster headache and other trigeminal-autonomic cephalalgias. Eur J Neurol 2006, 13:1066–1077.

    Article  CAS  PubMed  Google Scholar 

  48. Cohen AS, Matharu MS, Goadsby PJ: Electrocardiographic abnormalities in patients with cluster headache on verapamil therapy. Neurology 2007, 69:668–675.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Koen Paemeleire.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Paemeleire, K., Evers, S. & Goadsby, P.J. Medication-overuse headache in patients with cluster headache. Current Science Inc 12, 122–127 (2008). https://doi.org/10.1007/s11916-008-0023-4

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-008-0023-4

Keywords

Navigation